Regenxbio Inc (RGNX)

Regenxbio Inc (RGNX) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
기간	3개월	3개월	3개월	3개월	3개월
Revenues	1,590%108.02	6.39	30.34	29.73	21.36
	2.19%56.09	57.34	-	-	-
Research and Development	2.19%56.09	57.34	-	-	-
Costs And Expenses	12.25%78.76	89.76	87.97	82.14	84.64
Depreciation and Amortization	2.59%3.76	3.86	3.87	3.89	3.91
Operating Income/Loss	135.10%29.26	-83.36	-57.64	-52.41	-63.28
Nonoperating Income/Loss	2.02%-6.55	-6.69	-9.51	-9.53	-7.59
	125.22%22.71	-90.05	-67.15	-61.94	-70.87
Attributable To Parent	125.22%22.71	-90.05	-67.15	-61.94	-70.87
Basic Average Shares	0.75%52.82	52.43	0.06	51.69	51.48
Diluted Average Shares	1.12%53.02	52.43	0.06	51.69	51.48
Basic Earnings Per Share	125.00%0.43	-1.72	-1.30	-1.20	-1.38
Diluted Earnings Per Share	125.00%0.43	-1.72	-1.30	-1.20	-1.38